1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Blood Typing, Grouping and Infectious Disease Screening Market
2.2. Global Blood Typing, Grouping and Infectious Disease Screening Market, By Test, 2023 (US$ Million)
2.3. Global Blood Typing, Grouping and Infectious Disease Screening Market, By Product, 2023 (US$ Million)
2.4. Global Blood Typing, Grouping and Infectious Disease Screening Market, By Infectious Agent, 2023 (US$ Million)
2.5. Global Blood Typing, Grouping and Infectious Disease Screening Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Blood Typing, Grouping and Infectious Disease Screening Market: Competitive Analysis
3.1. Market Positioning of Key Blood Typing, Grouping and Infectious Disease Screening Market Vendors
3.2. Strategies Adopted by Blood Typing, Grouping and Infectious Disease Screening Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Blood Typing, Grouping and Infectious Disease Screening Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Blood Typing, Grouping and Infectious Disease Screening Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. ABO Grouping
5.3.2. Immunoassay Screening
5.3.3. Nucleic Acid Testing (NAT)

6. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Instruments
6.3.2. Consumables
6.3.3. Kits

7. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Hepatitis B Virus (HBV)
7.3.2. Hepatitis C Virus (HCV)
7.3.3. Human Immunodeficiency Virus (HIV)
7.3.4. Human T-Lymphotropic Virus (HTLV)
7.3.5. Treponema pallidum (T. palladium)
7.3.6. Trypanosoma cruzi (T. cruzi)
7.3.7. West Nile Virus (WNV)
7.3.8. Cytomegalovirus (CMV)
7.3.9. Other Agents (Parvovirus, Ebola Virus, etc.)


8. North America Blood Typing, Grouping and Infectious Disease Screening Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
8.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
8.4. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
8.5.Blood Typing, Grouping and Infectious Disease Screening Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
8.5.1.1.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
8.5.1.1.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
8.5.1.2.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
8.5.1.2.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
8.5.1.3.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
8.5.1.3.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)

9. UK and European Union Blood Typing, Grouping and Infectious Disease Screening Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
9.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
9.4. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
9.5.Blood Typing, Grouping and Infectious Disease Screening Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
9.5.1.1.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
9.5.1.1.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
9.5.1.2.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
9.5.1.2.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
9.5.1.3.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
9.5.1.3.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
9.5.1.4.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
9.5.1.4.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
9.5.1.5.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
9.5.1.5.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
9.5.1.6.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
9.5.1.6.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)

10. Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
10.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
10.4. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
10.5.Blood Typing, Grouping and Infectious Disease Screening Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
10.5.1.1.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
10.5.1.1.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
10.5.1.2.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
10.5.1.2.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
10.5.1.3.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
10.5.1.3.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
10.5.1.4.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
10.5.1.4.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
10.5.1.5.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
10.5.1.5.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
10.5.1.6.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
10.5.1.6.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)

11. Latin America Blood Typing, Grouping and Infectious Disease Screening Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
11.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
11.4. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
11.5.Blood Typing, Grouping and Infectious Disease Screening Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
11.5.1.1.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
11.5.1.1.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
11.5.1.2.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
11.5.1.2.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
11.5.1.3.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
11.5.1.3.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)

12. Middle East and Africa Blood Typing, Grouping and Infectious Disease Screening Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
12.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
12.4. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
12.5.Blood Typing, Grouping and Infectious Disease Screening Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
12.5.1.1.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
12.5.1.1.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
12.5.1.2.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
12.5.1.2.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Blood Typing, Grouping and Infectious Disease Screening Market: By Test, 2022-2032, USD (Million)
12.5.1.3.2. Blood Typing, Grouping and Infectious Disease Screening Market: By Product, 2022-2032, USD (Million)
12.5.1.3.3. Blood Typing, Grouping and Infectious Disease Screening Market: By Infectious Agent, 2022-2032, USD (Million)

13. Company Profile
13.1. Abbott Laboratories, Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Becton, Dickinson and Company
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. bioMerieux SA
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Bio-Rad Laboratories, Inc.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. DiaSorin S.p.A
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. F. Hoffmann-La Roche Ltd.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Grifols S.A
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Immucor, Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Ortho Clinical Diagnostics
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Quotient Ltd.
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Thermo Fisher Scientific, Inc.
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives